An Open-Label, Dose Escalation, Safety, and Pharmacokinetic Study of ENMD-2076 Administered Orally to Patients with Advanced Cancer.

Research output: Contribution to journalArticlepeer-review

Original languageAmerican English
JournalJournal of Clinical Oncology
StatePublished - 2009

Disciplines

  • Medicine and Health Sciences

Cite this